https://sernova.com/press_releases/sernova-to-participate-at-the-biotech-showcase-2018-healthcare-partnering-conference/ 2018-01-05T00:00:00+00:00 https://sernova.com/press_releases/sernovas-cell-pouch-regenerative-medicine-clinical-trial-for-patients-with-type-1-diabetes-supported-with-continuous-glucose-monitoring-systems/ 2018-02-22T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-results-of-2018-annual-general-meeting-of-shareholders-and-new-chief-financial-officer/ 2018-05-04T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-u-s-phase-i-ii-cell-pouch-clinical-trial-with-prominent-diabetes-clinical-investigator/ 2018-05-08T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-university-of-chicago-institutional-review-board-irb-approval-of-the-fda-cleared-therapeutic-cell-pouch-clinical-study/ 2018-05-14T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-2-million-private-placement-financing/ 2018-06-26T00:00:00+00:00 https://sernova.com/press_releases/sernova-initiates-patient-screening-and-recruitment-for-its-us-clinical-trial-for-diabetes/ 2018-07-05T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-2000000-first-closing-of-private-placement/ 2018-07-16T00:00:00+00:00 https://sernova.com/press_releases/sernova-completes-oversubscribed-private-placement-of-2754000/ 2018-07-23T00:00:00+00:00 https://sernova.com/press_releases/sernova-hemacure-consortium-to-present-achievements-in-development-of-a-regenerative-medicine-approach-to-treat-hemophilia-a/ 2018-10-23T00:00:00+00:00 https://sernova.com/press_releases/sernova-establishes-comprehensive-north-american-investor-relations-and-communications-strategy/ 2018-11-06T00:00:00+00:00 https://sernova.com/press_releases/sernova-retains-frontier-flex-for-canadian-investor-relations-and-marketing/ 2018-11-09T00:00:00+00:00 https://sernova.com/press_releases/sernova-highlights-achievements-from-the-hemacure-consortium-in-developing-a-novel-cell-based-therapy-for-hemophilia-a/ 2018-11-20T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-enrollment-of-first-patient-in-u-s-phase-i-ii-study-of-cell-pouch-for-treatment-in-type-1-diabetes/ 2018-12-20T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-successful-enrollment-approaching-50-of-subjects-in-its-u-s-phase-i-ii-cell-pouch-diabetes-clinical-trial/ 2019-01-17T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-on-diabetes-panel-and-present-at-nobleconxv-15th-annual-investor-conference-january-28th-29th-2019/ 2019-01-28T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-the-appointment-of-dr-david-lillicrap-m-d-to-its-scientific-advisory-board/ 2019-01-30T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-announces-first-patient-implanted-with-sernova-cell-pouch-in-a-phase-i-ii-us-clinical-trial-for-the-treatment-of-hypoglycemia-unawareness-in-subjects-with-type-1-diabetes/ 2019-02-11T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-first-transplantation-of-therapeutic-cells-in-cell-pouch-for-the-company-phase-i-ii-u-s-clinical-study-for-diabetes/ 2019-04-11T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-collaboration-to-advance-therapeutic-cell-pouch-technologies-for-the-treatment-of-hypothyroidism/ 2019-04-30T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-announces-appointment-of-deborah-brown-to-its-board-of-directors/ 2019-05-21T00:00:00+00:00 https://sernova.com/press_releases/sernovas-principal-investigator-to-present-interim-data-from-the-companys-ongoing-phase-i-ii-cell-pouch-clinical-trial-at-the-17th-world-congress-of-the-international-pancreas-and-islet-transplant-ass/ 2019-06-27T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-presents-positive-preliminary-safety-and-efficacy-data-in-its-phase-i-ii-clinical-trial-for-type-1-diabetes/ 2019-07-03T00:00:00+00:00 https://sernova.com/press_releases/sernova-phase-i-ii-us-clinical-trial-for-type-1-diabetes-advances-following-positive-preliminary-safety-and-efficacy-data/ 2019-07-17T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-up-to-3-million-private-placement-financing/ 2019-07-25T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-first-closing-of-private-placement/ 2019-08-19T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-second-closing-of-private-placement/ 2019-09-03T00:00:00+00:00 https://sernova.com/press_releases/sernova-completes-oversubscribed-private-placement-of-4684564/ 2019-09-10T00:00:00+00:00 https://sernova.com/press_releases/sernova-renews-frontier-flex-for-canadian-investor-relations-and-marketing/ 2019-09-17T00:00:00+00:00 https://sernova.com/press_releases/sernova-confirms-enduring-levels-of-fasting-c-peptide-in-bloodstream-of-first-patient-in-its-phase-i-ii-clinical-trial-for-type-1-diabetes/ 2019-10-16T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-biotech-veteran-as-new-chief-financial-officer/ 2019-10-24T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-positive-dsmb-review-and-recommendation-for-continuation-of-phase-i-ii-diabetes-clinical-trial-of-cell-pouch/ 2020-02-10T00:00:00+00:00 https://sernova.com/press_releases/sernova-achieves-positive-efficacy-endpoint-in-phase-i-ii-clinical-trial-for-type-1-diabetes/ 2020-02-13T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-corporate-update-at-noble-capital-markets-investor-conference/ 2020-02-17T00:00:00+00:00 https://sernova.com/press_releases/sernova-provides-corporate-update-and-outlook-for-2020/ 2020-03-24T00:00:00+00:00 https://sernova.com/press_releases/important-covid-19-safety-measures-for-sernova-s-2020-annual-meeting-of-shareholders/ 2020-04-21T00:00:00+00:00 https://sernova.com/press_releases/sernova-advances-annual-general-meeting-and-ceo-teleconference-to-friday-may-29/ 2020-04-27T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-presentation-of-hemacure-hemophilia-program-results-at-23rd-annual-meeting-of-the-american-society-of-gene-and-cell-therapy/ 2020-05-12T00:00:00+00:00 https://sernova.com/press_releases/sernova-highlights-achievements-of-the-hemacure-hemophilia-cell-therapy-program-presented-at-asgct/ 2020-05-19T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-change-of-location-of-annual-meeting-of-shareholders/ 2020-05-26T00:00:00+00:00 https://sernova.com/press_releases/agex-therapeutics-and-sernova-to-collaborate-to-engineer-universal-locally-immune-protected-cell-therapies-for-type-i-diabetes-and-hemophilia-a/ 2020-05-29T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-clinical-validation-of-the-cell-pouch-as-a-viable-safe-site-for-diabetes-cell-therapy-at-the-american-diabetes-association-virtual-80th-scientific-sessions/ 2020-06-03T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-acquire-cellular-local-immune-protection-technology-accelerating-expansion-of-its-regenerative-medicine-therapeutics-platform/ 2020-06-08T00:00:00+00:00 https://sernova.com/press_releases/sernova-completes-acquisition-of-cellular-local-immune-protection-technology/ 2020-06-15T00:00:00+00:00 https://sernova.com/press_releases/sernova-highlights-positive-results-presented-at-the-american-diabetes-association-s-virtual-80th-scientific-sessions/ 2020-06-18T00:00:00+00:00 https://sernova.com/press_releases/dr-anke-m-schulte-joins-sernova-global-advisory-board/ 2020-07-16T00:00:00+00:00 https://sernova.com/press_releases/sernova-enters-into-exclusive-worldwide-license-agreement-with-university-of-miami-for-therapeutic-cell-immune-protection-technologies/ 2020-08-04T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-up-to-3-million-private-placement-financing-with-a-lead-order-of-2-million/ 2020-09-09T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-cell-and-gene-therapies-for-chronic-conditions-panel-at-the-virtual-2020-cell-gene-meeting-on-the-mesa-conference/ 2020-09-10T00:00:00+00:00 https://sernova.com/press_releases/sernova-closes-oversubscribed-private-placement-and-accelerates-development-programs/ 2020-09-22T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-at-virtual-bio-investor-forum/ 2020-09-24T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-at-tsx-life-sciences-investor-day/ 2020-10-27T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-3-month-extension-of-warrants/ 2020-10-30T00:00:00+00:00 https://sernova.com/press_releases/sernova-provides-clinical-update-on-u-s-phase-i-ii-cell-pouch-trial-for-type-1-diabetes/ 2020-11-18T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-clinical-trial-investigator-presentation-at-the-asts-21st-winter-symposium/ 2020-11-30T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-at-h-c-wainwright-bioconnect-2021-conference/ 2020-12-18T00:00:00+00:00 https://sernova.com/press_releases/sernova-principal-investigator-presents-additional-positive-preliminary-safety-and-efficacy-data-from-ongoing-u-s-phase-i-ii-cell-pouch-clinical-trial-for-type-1-diabetes/ 2021-01-15T00:00:00+00:00 https://sernova.com/press_releases/sernova-ceo-to-present-regenerative-medicine-therapeutics-platform-update-at-the-2021-cell-gene-meeting-on-the-med/ 2021-01-21T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-warrants-exercise-for-proceeds-of-4-3-million-and-early-conversion-of-debenture/ 2021-01-25T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-collaboration-agreements-with-multiple-pharmaceutical-industry-leaders/ 2021-01-28T00:00:00+00:00 https://sernova.com/press_releases/sernovas-collaborator-to-present-cell-pouch-thyroid-transplant-study-results-at-the-american-association-of-endocrine-surgeons-2021-annual-meeting/ 2021-02-03T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-announces-c10-million-bought-deal-offering-of-units/ 2021-02-03T00:00:00+00:00 https://sernova.com/press_releases/sernova-shares-accepted-for-trading-on-the-electronic-trading-platform-xetra-in-germany/ 2021-02-04T00:00:00+00:00 https://sernova.com/press_releases/sernova-upsizes-previously-announced-bought-deal-public-offering-to-c20-million/ 2021-02-04T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-second-annual-data-safety-monitoring-board-review-of-its-diabetes-cell-pouch-system-clinical-trial-and-recommendation-for-protocol-continuation/ 2021-02-18T00:00:00+00:00 https://sernova.com/press_releases/sernova-obtains-final-prospectus-receipt-for-20-million-bought-deal/ 2021-02-24T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-selected-for-the-tsx-venture-stock-exchanges-2021-venture-50-list-of-top-performing-listed-companies/ 2021-02-25T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-closing-of-c23-million-bought-deal-financing-including-full-exercise-of-over-allotment-option/ 2021-03-01T00:00:00+00:00 https://sernova.com/press_releases/sernova-provides-positive-outlook-regarding-the-development-of-its-innovative-therapeutics-platform-technology-for-chronic-diseases/ 2021-03-15T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-presentation-at-the-american-diabetes-association-81st-scientific-sessions/ 2021-04-06T00:00:00+00:00 https://sernova.com/press_releases/sernova-appoints-internationally-renowned-thyroid-disease-expert-dr-sam-wiseman-to-its-scientific-advisory-board/ 2021-04-14T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-host-a-virtual-key-opinion-leader-event-on-thyroid-disease-and-the-potential-for-its-cell-therapy-as-a-novel-treatment-approach/ 2021-04-21T00:00:00+00:00 https://sernova.com/press_releases/sernova-kol-event-highlights-novel-cell-therapy-approach-for-the-potential-treatment-of-thyroid-disease/ 2021-04-28T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-the-nomination-of-seasoned-pharma-executive-dr-mohammad-azab-to-its-board-of-directors/ 2021-05-04T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-at-global-partnership-family-office-healthcare-biotechnology-tsx-showcase/ 2021-05-17T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-american-transplant-congress-2021virtual-connect-abstract-presentation/ 2021-06-01T00:00:00+00:00 https://sernova.com/press_releases/sernovas-principal-investigator-presents-positive-new-data-from-ongoing-type-1-diabetes-t1d-clinical-trial-at-atc-2021-virtual-connect-conference/ 2021-06-07T00:00:00+00:00 https://sernova.com/press_releases/sernovas-principal-investigator-presents-interim-data-and-positive-patient-outcomes-of-phase-i-ii-t1d-study-at-the-american-diabetes-association-81st-scientific-sessions/ 2021-06-27T00:00:00+00:00 https://sernova.com/press_releases/industry-veteran-frank-shannon-joins-sernova-as-vp-clinical-development-and-regulatory-affairs/ 2021-06-30T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-2021-annual-meeting-results-shareholders-approve-resolutions-with-overwhelming-majority/ 2021-07-05T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-corporate-update-at-canaccord-genuitys-41st-annual-growth-conference/ 2021-08-09T00:00:00+00:00 https://sernova.com/press_releases/sernova-signs-collaboration-agreement-to-advance-conformal-coated-immune-protected-therapeutic-cells-for-diabetes-with-the-university-of-miami/ 2021-09-16T00:00:00+00:00 https://sernova.com/press_releases/sernova-engages-new-york-based-lifesci-advisors-as-us-investor-relations-partner/ 2021-09-29T00:00:00+00:00 https://sernova.com/press_releases/sernova-the-ultimate-combination-of-two-proven-technologies-as-potential-functional-cure-for-type1-diabetes-and-other-chronic-diseases/ 2021-10-01T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-and-digital-health-services-forum/ 2021-11-16T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-appointment-of-executive-chair-to-complement-its-management-team/ 2021-12-02T00:00:00+00:00 https://sernova.com/press_releases/sernova-appoints-christopher-barnes-as-vice-president-investor-relations-grants-options-dsus/ 2021-12-14T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-clinical-investigator-update-of-its-type-1-diabetes-trial-at-the-2022-asts-22nd-annual-winter-symposium/ 2021-12-16T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-announce-new-interim-results-of-its-type-1-diabetes-clinical-trial-during-the-40th-annual-j-p-morgan-healthcare-conference/ 2022-01-05T00:00:00+00:00 https://sernova.com/press_releases/the-principal-investigator-in-sernovas-type-1-diabetes-t1d-trial-confirms-patients-with-a-history-of-hypoglycemia-unawareness-are-now-insulin-independent/ 2022-01-10T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-peer-reviewed-publication-demonstrating-safety-and-efficacy-of-a-novel-cell-pouch-cell-therapy-approach-for-treatment-of-severe-hemophilia-a/ 2022-01-20T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-peer-reviewed-publication-demonstrating-positive-preclinical-safety-and-efficacy-indicators-of-its-novel-cell-pouch-system-therapeutic-approach-for-treatment-of-thyroid-dise/ 2022-01-27T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-ranks-among-top-50-performing-companies-on-the-2022-tsx-venture-list/ 2022-02-24T00:00:00+00:00 https://sernova.com/press_releases/data-safety-monitoring-board-recommends-continuation-of-phase-1-2-clinical-trial-with-sernovas-cell-pouch-system-in-patients-with-type-1-diabetes/ 2022-03-17T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-2022-annual-general-meeting-results/ 2022-04-29T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-multiple-u-s-healthcare-investor-conferences/ 2022-05-05T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-abstract-on-phase-1-2-trial-with-cell-pouch-selected-for-oral-podium-presentation-at-american-diabetes-association-82nd-scientific-sessions-2022/ 2022-05-09T00:00:00+00:00 https://sernova.com/press_releases/sernova-and-evotec-enter-into-an-exclusive-global-strategic-partnership-for-ipsc-based-beta-cell-replacement-therapy-to-develop-and-commercialize-a-functional-cure-for-diabetes/ 2022-05-17T00:00:00+00:00 https://sernova.com/press_releases/sernova-receives-conditional-approval-to-up-list-to-the-toronto-stock-exchange/ 2022-05-24T00:00:00+00:00 https://sernova.com/press_releases/sernova-shares-to-commence-trading-on-tsx-on-june-2-2022/ 2022-06-01T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-positive-updated-phase-1-2-clinical-data-on-cell-pouch-system-at-american-diabetes-association-82nd-scientific-sessions-2022/ 2022-06-06T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-the-truist-securities-cell-therapy-symposium-symposia-cel-in-june/ 2022-06-15T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-live-investor-event-hosted-by-leede-jones-gable-inc/ 2022-08-30T00:00:00+00:00 https://sernova.com/press_releases/sernova-receives-second-tranche-equity-investment-from-evotec-of-6-8-million-at-a-price-of-2-50-per-share/ 2022-09-01T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-the-appointment-of-daniel-mahony-ph-d-to-its-board-of-directors/ 2022-09-07T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-at-h-c-wainwright-annual-global-investment-conference-and-lifesci-partners-healthtech-symposium/ 2022-09-08T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-full-exercise-of-share-purchase-warrants-expiring-september-22-2022/ 2022-09-22T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-the-roth-inaugural-healthcare-opportunities-conference/ 2022-09-28T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-announces-change-of-auditor/ 2022-10-24T00:00:00+00:00 https://sernova.com/press_releases/sernova-receives-authorization-to-enroll-second-patient-cohort-of-phase-1-2-trial-with-cell-pouch-system-for-type-1-diabetes/ 2022-11-03T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-the-stifel-healthcare-conference/ 2022-11-04T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-first-two-patients-implanted-with-cell-pouch-in-the-second-cohort-of-its-us-phase-1-2-clinical-trial-for-type-1-diabetes/ 2022-11-17T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-announces-ceo-succession-plan-and-expanded-management-team/ 2022-12-06T00:00:00+00:00 https://sernova.com/press_releases/sernova-and-evotec-on-track-to-initiate-clinical-testing-of-the-first-ipsc-derived-islets-in-cell-pouch-as-a-potential-functional-cure-for-type-1-diabetes/ 2023-01-10T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-advancements-with-its-novel-cell-pouch-systemtm-to-preserve-thyroid-function-following-total-thyroidectomy/ 2023-01-30T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-upcoming-roth-and-oppenheimer-investor-conferences/ 2023-03-02T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-initial-islet-transplantation-in-first-two-patients-enrolled-in-second-cohort-of-its-u-s-phase-1-2-clinical-trial-for-treatment-of-type-1-diabetes/ 2023-03-08T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-upcoming-podium-presentation-of-ipsc-and-cell-pouch-combination-treatment-for-type-one-diabetes-at-the-4th-ipita-hsci-jdrf-summit/ 2023-03-14T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-abstract-on-first-cohort-of-its-phase-1-2-study-involving-islet-allotransplantation-into-pre-vascularized-cell-pouch-selected-for-oral-podium-presentation-at-american-diabet/ 2023-03-22T00:00:00+00:00 https://sernova.com/press_releases/sernova-responds-to-dissident-shareholders-misleading-statements-and-provides-corporate-updates/ 2023-04-06T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-at-2023-alliance-for-regenerative-medicine-cell-gene-meeting-on-the-med/ 2023-04-10T00:00:00+00:00 https://sernova.com/press_releases/institutional-shareholder-services-inc-recommends-sernovas-shareholders-vote-for-all-management-nominees-on-managements-white-proxy/ 2023-04-14T00:00:00+00:00 https://sernova.com/press_releases/two-independent-proxy-advisory-firms-including-glass-lewis-co-llc-recommend-sernovas-shareholders-vote-for-all-management-nominees-on-managements-white-proxy/ 2023-04-18T00:00:00+00:00 https://sernova.com/press_releases/sernova-reminds-shareholders-to-vote-for-the-eight-management-director-nominees-using-only-the-white-management-proxy/ 2023-04-21T00:00:00+00:00 https://sernova.com/press_releases/successful-results-using-sernovas-cell-pouch-system-with-evotecs-ipsc-derived-islet-like-clusters-for-type-1-diabetes-presented-at-the-4th-ipita-hsci-jdrf-summit/ 2023-04-24T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-announces-voting-results-of-the-2023-annual-general-meeting-of-shareholders/ 2023-04-28T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-research-collaboration-with-astrazeneca-to-evaluate-novel-potential-therapeutic-cell-applications/ 2023-05-03T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-executive-alignment-and-appoints-new-board-chair/ 2023-05-31T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-upcoming-truist-securities-cell-therapy-symposium/ 2023-06-16T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-updated-interim-phase-1-2-clinical-data-on-cell-pouch-system-during-oral-presentation-at-american-diabetes-association-83rd-scientific-sessions/ 2023-06-22T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-positive-updated-interim-phase-1-2-clinical-data-for-the-cell-pouch-system-at-american-diabetes-association-83rd-scientific-sessions/ 2023-06-26T00:00:00+00:00 https://sernova.com/press_releases/sernova-expands-leadership-team-with-appointment-of-modestus-obochi-ph-d-mba-as-chief-business-officer/ 2023-07-26T00:00:00+00:00 https://sernova.com/press_releases/sernova-corporation-announces-the-appointment-of-cynthia-pussinen-as-ceo/ 2023-09-05T00:00:00+00:00 https://sernova.com/press_releases/sernova-provides-development-update-on-proprietary-cellular-conformal-coating-technology-in-combination-with-cell-pouch-device/ 2023-09-07T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-host-investor-calls-to-introduce-newly-appointed-ceo-and-provide-business-update/ 2023-09-13T00:00:00+00:00 https://sernova.com/press_releases/sernova-investor-conference-call-previously-scheduled-for-september-15-now-rescheduled-for-september-22/ 2023-09-14T00:00:00+00:00 https://sernova.com/press_releases/sernova-presents-compelling-new-data-on-the-cell-pouch-system-as-a-promising-treatment-for-post-operative-hypothyroidism-at-the-2023-american-thyroid-association-annual-meeting/ 2023-09-29T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-provide-two-program-updates-in-podium-presentations-at-2023-ipita-congress/ 2023-10-11T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-positive-ongoing-interim-phase-1-2-clinical-data-for-the-cell-pouch-system-for-type-1-diabetes-trial-at-the-2023-ipita-ixa-and-ctrms-joint-congress/ 2023-10-27T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-new-advancements-of-conformal-coating-technology-in-combination-with-the-cell-pouch-system-at-the-2023-ipita-ixa-ctrms-joint-congress/ 2023-10-30T00:00:00+00:00 https://sernova.com/press_releases/sernova-receives-orphan-drug-and-rare-pediatric-disease-designations-for-its-hemophilia-a-program-from-fda/ 2023-11-27T00:00:00+00:00 https://sernova.com/press_releases/sernova-provides-recap-of-2023-accomplishments-and-anticipated-2024-milestones/ 2024-01-29T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-management-developments/ 2024-03-11T00:00:00+00:00 https://sernova.com/press_releases/sernova-provides-positive-clinical-and-platform-portfolio-update/ 2024-04-02T00:00:00+00:00 https://sernova.com/press_releases/sernova-welcomes-dr-bernd-muehlenweg-as-evotecs-nominee-for-its-board-of-directors/ 2024-04-22T00:00:00+00:00 https://sernova.com/press_releases/sernova-provides-organizational-update/ 2024-04-25T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-agm-voting-results/ 2024-05-01T00:00:00+00:00 https://sernova.com/press_releases/sernova-appoints-jonathan-rigby-to-its-board-of-directors/ 2024-05-28T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-marketed-public-offering-of-units/ 2024-06-11T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-additional-patient-insulin-independent-and-cohort-2-enrollment-complete-in-ongoing-phase-i-ii-clinical-trial-for-treatment-of-type-1-diabetes/ 2024-06-25T00:00:00+00:00 https://sernova.com/press_releases/jonathan-rigby-appointed-as-executive-chairman-for-sernova/ 2024-07-15T00:00:00+00:00 https://sernova.com/press_releases/sernova-corp-announces-appointment-of-new-chief-executive-officer/ 2024-08-12T00:00:00+00:00 https://sernova.com/press_releases/lead-investigator-for-sernovas-clinical-trial-with-cell-pouch-for-type-1-diabetes-to-deliver-oral-presentation-at-the-2024-easd-annual-meeting/ 2024-08-15T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-up-to-4-million-private-placement-priced-at-a-premium/ 2024-08-20T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-oversubscribed-non-brokered-private-placement/ 2024-08-29T00:00:00+00:00 https://sernova.com/press_releases/sernova-closes-5-2-million-over-subscribed-non-brokered-private-placement/ 2024-09-04T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-participate-in-upcoming-h-c-wainwright-investor-conference/ 2024-09-05T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-new-positive-data-from-phase-i-ii-trial-regarding-islet-survival-and-function/ 2024-09-12T00:00:00+00:00 https://sernova.com/press_releases/sernova-appoints-david-paterson-ph-d-to-its-board-of-directors/ 2024-09-19T00:00:00+00:00 https://sernova.com/press_releases/sernova-to-present-at-the-2024-cell-gene-meeting-on-the-mesa/ 2024-10-03T00:00:00+00:00 https://sernova.com/press_releases/sernova-announces-key-new-executive-appointments/ 2024-10-11T00:00:00+00:00 https://sernova.com/press_releases/sernova-update-on-strategic-initiatives/ 2025-01-06T10:49:31+00:00 https://sernova.com/press_releases/sernova-reschedules-its-annual-general-and-special-meeting-of-shareholders-to-january-10-2025/ 2025-01-06T10:50:24+00:00 https://sernova.com/press_releases/sernova-announces-voting-results-from-its-annual-and-special-general-meeting-of-shareholders/ 2025-01-13T08:00:00+00:00 https://sernova.com/press_releases/sernova-announces-appointment-of-ross-haghighat-as-chair-of-the-board-and-a-change-of-name-to-sernova-biotherapeutics/ 2025-01-30T08:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-submits-ind-application-for-its-cell-pouch-bio-hybrid-organ-with-autograft-thyroid-cells-in-patients-with-hypothyroidism/ 2025-02-03T08:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-receives-fda-clearance-for-ind-application-for-its-cell-pouch-bio-hybrid-organ-with-autograft-thyroid-cells-in-patients-with-hypothyroidism/ 2025-03-03T09:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-secures-1-million-convertible-debt-financing/ 2025-03-05T08:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-appoints-pericles-calias-ph-d-as-chief-development-officer-and-head-of-rd/ 2025-03-10T08:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-provides-update-on-phase-1-2-clinical-trial-of-cell-pouch-bio-hybrid-organ-for-treatment-of-type-1-diabetes/ 2025-04-01T08:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-cell-pouch-bio-hybrid-organ-to-be-highlighted-at-cell-gene-meeting-on-the-med/ 2025-04-15T04:05:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-secures-4-million-loan-to-further-advance-its-clinical-development-plans/ 2025-04-17T08:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-provides-positive-interim-data-from-ongoing-phase-1-2-clinical-trial-of-cell-pouch-bio-hybrid-organ-in-patients-living-with-type-1-diabetes/ 2025-05-14T07:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-appoints-world-class-clinical-advisory-board-to-support-development-of-cell-pouch-bio-hybrid-organ-as-functional-cure-for-type-1-diabetes/ 2025-05-22T07:00:00+00:00 https://sernova.com/press_releases/chair-of-sernova-biotherapeutics-resigns/ 2025-05-29T09:55:58+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-announces-collaboration-with-eledon-pharmaceuticals-to-advance-a-potential-functional-cure-for-type-1-diabetes/ 2025-07-09T08:30:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-announces-13-million-debt-to-equity-conversion-eliminating-significant-financing-overhang/ 2025-10-09T09:13:29+00:00 https://sernova.com/press_releases/sernova-appoints-jonathan-rigby-as-interim-chair/ 2025-10-09T09:15:10+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-appoints-john-l-brooks-iii-former-chair-and-ceo-of-joslin-diabetes-research-center-as-chair-of-the-board-of-directors/ 2025-10-09T09:16:39+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-closes-first-tranche-of-a-private-placement-of-equity-financing-to-support-ongoing-clinical-efforts/ 2026-01-05T11:34:51+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-strengthens-balance-sheet-with-7-1-million-in-financings-plus-net-retirement-of-a-cumulative-17-million-of-debt-subject-to-shareholder-approval/ 2026-03-04T10:31:41+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-announces-warrant-amendments/ 2026-03-04T17:28:15+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-announces-close-of-non-brokered-private-placement-financing/ 2026-04-01T14:07:46+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-announces-affirmative-voting-results-from-2026-annual-general-meeting-of-shareholders/ 2026-04-09T08:21:38+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-announces-closing-of-recently-approved-financings/ 2026-04-27T09:55:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-receives-fda-orphan-drug-designation-for-autologous-islet-transplantation-for-prevention-of-diabetes-due-to-total-pancreatectomy-2/ 2026-06-17T07:00:00+00:00 https://sernova.com/press_releases/sernova-and-seraxis-enter-definitive-merger-agreement-to-create-a-differentiated-type-1-diabetes-islet-cell-replacement-biotech-company-betanova-biotherapeutics/ 2026-09-08T07:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-to-participate-in-the-h-c-wainwright-28th-annual-global-investor-conference/ 2026-09-10T07:00:00+00:00 https://sernova.com/press_releases/sernova-biotherapeutics-to-participate-in-noble-capital-markets-emerging-growth-virtual-equity-conference/ 2026-09-25T07:00:00+00:00 https://sernova.com/press_releases/sernova-and-seraxis-close-us11-2-million-financing-to-fund-merger-to-become-betanova-biotherapeutics-and-advance-type-1-diabetes-cell-therapy-into-near-term-phase-1-2-clinical-trial/ 2026-10-05T07:00:00+00:00